Pharmaceuticals: Survival of the 'Fittest': AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline and Wyeth: Can competitive advantage be sustained without M&A in the wake of Pfizer/Pharmacia?
Datamonitor January 7, 2003 37 Pages - Pub ID: DFMN855793
Biomet, Inc. Market Share Analysis
By: GlobalData
Biomet, Inc. Market Share Analysis
Description
This report is an essential source for data, analysis and strategic insight into the medical equipment business of Biomet, Inc. The report provides key information relating to
|
more...Search inside this report
11/11/2009
$1,000.00
Takeda Pipeline, Products, Performance, Potential
By: Espicom Healthcare Intelligence
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to
|
more...Search inside this report
11/10/2009
$1,130.00
Merck & Co. Performance, Products, Pipeline and Potential
By: Espicom Healthcare Intelligence
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to
|
more...Search inside this report
11/10/2009
$1,130.00
Les Laboratoires Servier: PharmaVitae Profile
By: Datamonitor
Introduction This analysis examines the historical and forecast performance for Servier in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts
|
more...
11/4/2009
$5,700.00
King Pharmaceuticals Inc.: PharmaVitae Profile
By: Datamonitor
Introduction This analysis examines the historical and forecast performance for King in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts
|
more...
11/2/2009
$5,700.00
Asia Pacific Pharma Sector Analysis
By: RNCOS
The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region
|
more...
Top 50 Pharmaceutical Companies Report
By: Plimsoll Publishing Ltd.
The Global Top 50 Pharmaceutical Companies Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an
|
more...
11/1/2009
$1,300.00
Top 100 Pharmaceutical Manufacturers Industry Analysis
By: Plimsoll Publishing Ltd.
The Global Top 100 Pharmaceutical Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an
|
more...
11/1/2009
$1,500.00
Pharmaceutical Manufacturers Report - Chinese
By: Plimsoll Publishing Ltd.
The Chinese Pharmaceutical Manufacturers Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial
|
more...